Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study

Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicina (Kaunas, Lithuania) Ročník 58; číslo 2; s. 219
Hlavní autoři: Lohan, Laura, Cool, Charlène, Viault, Loriane, Cestac, Philippe, Renard, Eric, Galtier, Florence, Villiet, Maxime, Avignon, Antoine, Sultan, Ariane, Breuker, Cyril
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland MDPI AG 01.02.2022
MDPI
Témata:
ISSN:1648-9144, 1010-660X, 1648-9144
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.
AbstractList Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities (study registered on ClinicalTrials.gov, NCT04391088).
Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.
: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. : This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. : A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. : Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.
Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities.
Author Galtier, Florence
Viault, Loriane
Cestac, Philippe
Breuker, Cyril
Cool, Charlène
Villiet, Maxime
Avignon, Antoine
Sultan, Ariane
Lohan, Laura
Renard, Eric
AuthorAffiliation 1 Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France; l-lohan_descamps@chu-montpellier.fr (L.L.); loriane.viault@aphp.fr (L.V.); m-villiet@chu-montpellier.fr (M.V.)
2 Phymedexp, University of Montpellier, INSERM, CNRS, CHRU de Montpellier, 34295 Montpellier, France; a-sultan@chu-montpellier.fr
3 Department of Pharmacy, Toulouse University Hospital, 31059 Toulouse, France; cool.c@chu-toulouse.fr (C.C.); cestac.p@chu-toulouse.fr (P.C.)
5 Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France; e-renard@chu-montpellier.fr (E.R.); f-galtier@chu-montpellier.fr (F.G.); a-avignon@chu-montpellier.fr (A.A.)
4 Centre for Epidemiology and Population Health Research (CERPOP), UMR 1027, INSERM, University of Toulouse (UPS), 31059 Toulouse, France
AuthorAffiliation_xml – name: 5 Endocrinology-Diabetology-Nutrition Department, University of Montpellier, 34295 Montpellier, France; e-renard@chu-montpellier.fr (E.R.); f-galtier@chu-montpellier.fr (F.G.); a-avignon@chu-montpellier.fr (A.A.)
– name: 4 Centre for Epidemiology and Population Health Research (CERPOP), UMR 1027, INSERM, University of Toulouse (UPS), 31059 Toulouse, France
– name: 1 Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, 34295 Montpellier, France; l-lohan_descamps@chu-montpellier.fr (L.L.); loriane.viault@aphp.fr (L.V.); m-villiet@chu-montpellier.fr (M.V.)
– name: 3 Department of Pharmacy, Toulouse University Hospital, 31059 Toulouse, France; cool.c@chu-toulouse.fr (C.C.); cestac.p@chu-toulouse.fr (P.C.)
– name: 2 Phymedexp, University of Montpellier, INSERM, CNRS, CHRU de Montpellier, 34295 Montpellier, France; a-sultan@chu-montpellier.fr
Author_xml – sequence: 1
  givenname: Laura
  surname: Lohan
  fullname: Lohan, Laura
– sequence: 2
  givenname: Charlène
  surname: Cool
  fullname: Cool, Charlène
– sequence: 3
  givenname: Loriane
  surname: Viault
  fullname: Viault, Loriane
– sequence: 4
  givenname: Philippe
  surname: Cestac
  fullname: Cestac, Philippe
– sequence: 5
  givenname: Eric
  orcidid: 0000-0002-3407-7263
  surname: Renard
  fullname: Renard, Eric
– sequence: 6
  givenname: Florence
  orcidid: 0000-0002-0720-6277
  surname: Galtier
  fullname: Galtier, Florence
– sequence: 7
  givenname: Maxime
  surname: Villiet
  fullname: Villiet, Maxime
– sequence: 8
  givenname: Antoine
  surname: Avignon
  fullname: Avignon, Antoine
– sequence: 9
  givenname: Ariane
  surname: Sultan
  fullname: Sultan, Ariane
– sequence: 10
  givenname: Cyril
  orcidid: 0000-0002-9023-2686
  surname: Breuker
  fullname: Breuker, Cyril
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35208544$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03563065$$DView record in HAL
BookMark eNp1kkuP0zAUhSM0iHnAnhWyxAYWBcd2HIcFUtUZaKVKIF5b68a5aV2ldnCSorLkl-O0M2imEitb9nfOfV4mZ847TJLnKX3DeUHfbrGyxjrIFGWUpcWj5CKVQk2KVIize_fz5LLrNpRyluXsSXLOM0ZVJsRF8mexbcH0xNdk7rvW9tDY39Bb74h1BBy5cZU3wTrf-NWeXGMLod-iiwpHfoAZox_omd9hgBWOss_o2wbJ0u6sW5Fftl-Tawsl9ti9I1PyBaGZLG2N5Gs_VPunyeMamg6f3Z5XyfcPN99m88ny08fFbLqcmIyJfgJKFHUKStZQCxTKFCljmGOWSyhFxTkTphaSozQqL5HynJcFgwpqSDFlOb9KFkffysNGt8FuIey1B6sPDz6sdKzNmga1wFoIzEtp0Ii0KkCVnNO8qlhZyrqE6PX-6NUOZRyCiQ0J0Dwwffjj7Fqv_E4rlRfFIZnXR4P1iWw-XerxjfJMciqzXRrZV7fBgv85YNfrre0MNg049EOnmeRcZTnPVERfnqAbPwQX2zpSrJAslyxSL-5n_y_-3VpEQB4BE3zXBay1iZsxzjkWYxudUj3unz7dvyikJ8I77_9K_gKG6uC6
CitedBy_id crossref_primary_10_4239_wjd_v15_i3_440
Cites_doi 10.1016/j.ebiom.2015.06.018
10.1016/j.ejim.2016.12.003
10.1016/j.ijcard.2018.04.068
10.2807/1560-7917.ES.2017.22.30.30580
10.1097/PTS.0000000000000764
10.1080/21645515.2020.1849518
10.2337/dc17-2131
10.3390/ijerph17217945
10.1016/j.vaccine.2016.10.042
10.1016/j.ebiom.2016.08.042
10.3390/vaccines8020292
10.2337/dc05-2517
10.1016/j.vaccine.2018.10.093
10.2337/dc14-2820
10.2337/diacare.20.7.1212
10.2337/dc19-S004
10.1016/j.sapharm.2020.08.021
10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O
10.1097/PTS.0000000000000420
10.3390/jcm10173967
10.1016/j.vaccine.2016.08.085
10.1093/ofid/ofu024
10.4161/hv.23926
10.1080/21645515.2021.1971473
10.1016/j.cmi.2015.06.017
10.1017/S095026889700825X
10.1080/21645515.2019.1587274
10.3390/medicina57121376
10.1186/s12889-018-5697-x
10.1007/s00125-020-05180-x
10.1016/j.amjmed.2015.10.031
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
1XC
VOOES
5PM
DOA
DOI 10.3390/medicina58020219
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

CrossRef
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1648-9144
ExternalDocumentID oai_doaj_org_article_4ef44e7b6cec41d9a8b3307dd2bb6fba
PMC8879927
oai:HAL:hal-03563065v1
35208544
10_3390_medicina58020219
Genre Journal Article
Observational Study
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID 0R~
29M
2WC
4.4
457
53G
5GY
5VS
7X7
8FI
8FJ
AADQD
AAEDT
AAFWJ
AAIKJ
AAYXX
ABMAC
ABUWG
ACGFS
ADBBV
ADEZE
AFFHD
AFKRA
AFPKN
AFZYC
AGHFR
AHDRD
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
EMOBN
F5P
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
ITC
KQ8
MODMG
O9-
OK1
OVT
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
XSB
0SF
AACTN
ALIPV
CGR
CUY
CVF
DIK
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
1XC
AAEDW
AALRI
AAXUO
AAYWO
ADVLN
AITUG
AMRAJ
EBS
EJD
IPNFZ
M41
RIG
ROL
SSZ
VOOES
5PM
ID FETCH-LOGICAL-c524t-a849f1a86faf4e48c9122e7e576ab4d3324cf463e6c87be0373b92adafa1e1273
IEDL.DBID DOA
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000767996200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1648-9144
1010-660X
IngestDate Fri Oct 03 12:52:32 EDT 2025
Tue Nov 04 01:44:05 EST 2025
Sat Oct 25 07:24:12 EDT 2025
Thu Oct 02 03:58:01 EDT 2025
Tue Oct 07 07:04:00 EDT 2025
Thu Jan 02 22:56:59 EST 2025
Sat Nov 29 07:16:20 EST 2025
Tue Nov 18 20:39:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords vaccination coverage
people living with diabetes
hospitalization
clinical pharmacist
Language English
License Attribution: http://creativecommons.org/licenses/by
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c524t-a849f1a86faf4e48c9122e7e576ab4d3324cf463e6c87be0373b92adafa1e1273
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
PMCID: PMC8879927
These authors contributed equally to this work.
ORCID 0000-0002-9023-2686
0000-0002-0720-6277
0000-0002-3407-7263
OpenAccessLink https://doaj.org/article/4ef44e7b6cec41d9a8b3307dd2bb6fba
PMID 35208544
PQID 2632962762
PQPubID 5046879
ParticipantIDs doaj_primary_oai_doaj_org_article_4ef44e7b6cec41d9a8b3307dd2bb6fba
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8879927
hal_primary_oai_HAL_hal_03563065v1
proquest_miscellaneous_2633857358
proquest_journals_2632962762
pubmed_primary_35208544
crossref_citationtrail_10_3390_medicina58020219
crossref_primary_10_3390_medicina58020219
PublicationCentury 2000
PublicationDate 2022-02-01
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Medicina (Kaunas, Lithuania)
PublicationTitleAlternate Medicina (Kaunas)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Verheij (ref_9) 2006; 29
Guillot (ref_33) 2020; 14
Selvais (ref_12) 1997; 20
Paterson (ref_37) 2016; 34
Carey (ref_1) 2018; 41
Colquhoun (ref_8) 1997; 119
ref_36
Magliano (ref_2) 2015; 38
ref_13
ref_34
ref_32
Breuker (ref_29) 2021; 17
ref_30
Verger (ref_22) 2015; 2
Wilson (ref_24) 2019; 15
Isenor (ref_25) 2016; 34
ref_19
ref_18
ref_17
ref_38
ref_15
Lu (ref_6) 2016; 129
Andreoni (ref_16) 2021; 17
Lohan (ref_41) 2021; 17
Hosmer (ref_31) 1997; 16
Cariou (ref_39) 2020; 63
Rondy (ref_10) 2017; 22
Shea (ref_3) 2014; 1
Taha (ref_7) 2021; 17
(ref_21) 2013; 9
Verger (ref_23) 2015; 21
ref_20
ref_42
Breuker (ref_43) 2018; 268
Patel (ref_28) 2021; 17
Shang (ref_11) 2018; 36
ref_27
ref_26
Breuker (ref_40) 2017; 38
ref_5
ref_4
Larson (ref_35) 2016; 12
Sultan (ref_14) 2020; 14
References_xml – volume: 14
  start-page: 6
  year: 2020
  ident: ref_33
  article-title: Le rapport à la vaccination des personnes diabétiques. Résultats préliminaires d’une étude auprès de 3731 personnes diabétiques
  publication-title: Méd. Mal. Métab.
– volume: 2
  start-page: 891
  year: 2015
  ident: ref_22
  article-title: Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2015.06.018
– ident: ref_30
– volume: 38
  start-page: 38
  year: 2017
  ident: ref_40
  article-title: Patients with diabetes are at high risk of serious medication errors at hospital: Interest of clinical pharmacist intervention to improve healthcare
  publication-title: Eur. J. Intern. Med.
  doi: 10.1016/j.ejim.2016.12.003
– volume: 268
  start-page: 195
  year: 2018
  ident: ref_43
  article-title: Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors
  publication-title: Int. J. Cardiol.
  doi: 10.1016/j.ijcard.2018.04.068
– ident: ref_5
– volume: 22
  start-page: 30580
  year: 2017
  ident: ref_10
  article-title: 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2017.22.30.30580
– volume: 17
  start-page: e1034
  year: 2021
  ident: ref_41
  article-title: Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors
  publication-title: J. Patient Saf.
  doi: 10.1097/PTS.0000000000000764
– ident: ref_34
– volume: 17
  start-page: 1858
  year: 2021
  ident: ref_7
  article-title: Risk factors for invasive meningococcal disease: A retrospective analysis of the French national public health insurance database
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.1080/21645515.2020.1849518
– volume: 41
  start-page: 513
  year: 2018
  ident: ref_1
  article-title: Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study
  publication-title: Diabetes Care
  doi: 10.2337/dc17-2131
– ident: ref_27
  doi: 10.3390/ijerph17217945
– volume: 34
  start-page: 6700
  year: 2016
  ident: ref_37
  article-title: Vaccine hesitancy and healthcare providers
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.10.042
– volume: 12
  start-page: 295
  year: 2016
  ident: ref_35
  article-title: The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.08.042
– ident: ref_32
  doi: 10.3390/vaccines8020292
– volume: 29
  start-page: 1771
  year: 2006
  ident: ref_9
  article-title: Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients
  publication-title: Diabetes Care
  doi: 10.2337/dc05-2517
– volume: 36
  start-page: 8047
  year: 2018
  ident: ref_11
  article-title: Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.10.093
– volume: 38
  start-page: 1274
  year: 2015
  ident: ref_2
  article-title: Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc14-2820
– volume: 20
  start-page: 1212
  year: 1997
  ident: ref_12
  article-title: Reported rates, incentives, and effectiveness of major vaccinations in 501 attendees at two diabetes clinics
  publication-title: Diabetes Care
  doi: 10.2337/diacare.20.7.1212
– ident: ref_18
– ident: ref_4
  doi: 10.2337/dc19-S004
– volume: 14
  start-page: 12
  year: 2020
  ident: ref_14
  article-title: Référentiel de la Société francophone du diabète (SFD): Vaccination chez la personne diabétique
  publication-title: Méd. Mal. Métab.
– volume: 17
  start-page: 2040
  year: 2021
  ident: ref_28
  article-title: Letter: Impact of the COVID-19 pandemic on pharmacist-administered vaccination services
  publication-title: Res. Soc. Adm. Pharm.
  doi: 10.1016/j.sapharm.2020.08.021
– volume: 16
  start-page: 965
  year: 1997
  ident: ref_31
  article-title: A comparison of goodness-of-fit tests for the logistic regression model
  publication-title: Stat. Med.
  doi: 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O
– volume: 17
  start-page: e645
  year: 2021
  ident: ref_29
  article-title: Medication Errors at Hospital Admission and Discharge: Risk Factors and Impact of Medication Reconciliation Process to Improve Healthcare
  publication-title: J. Patient Saf.
  doi: 10.1097/PTS.0000000000000420
– ident: ref_38
  doi: 10.3390/jcm10173967
– volume: 34
  start-page: 5708
  year: 2016
  ident: ref_25
  article-title: Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.08.085
– volume: 1
  start-page: ofu024
  year: 2014
  ident: ref_3
  article-title: Rates of pneumococcal disease in adults with chronic medical conditions
  publication-title: Open Forum Infect. Dis.
  doi: 10.1093/ofid/ofu024
– volume: 9
  start-page: 1326
  year: 2013
  ident: ref_21
  article-title: Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.4161/hv.23926
– volume: 17
  start-page: 4265
  year: 2021
  ident: ref_16
  article-title: Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.1080/21645515.2021.1971473
– ident: ref_15
– volume: 21
  start-page: 930.e1
  year: 2015
  ident: ref_23
  article-title: Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: A follow-up study from 2008 to 2011 in southeastern France
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2015.06.017
– ident: ref_13
– ident: ref_17
– ident: ref_36
– ident: ref_19
– volume: 119
  start-page: 335
  year: 1997
  ident: ref_8
  article-title: Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes
  publication-title: Epidemiol. Infect.
  doi: 10.1017/S095026889700825X
– ident: ref_20
– volume: 15
  start-page: 2423
  year: 2019
  ident: ref_24
  article-title: Seasonal influenza self-vaccination behaviours and attitudes among nurses in Southeastern France
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.1080/21645515.2019.1587274
– ident: ref_42
  doi: 10.3390/medicina57121376
– ident: ref_26
  doi: 10.1186/s12889-018-5697-x
– volume: 63
  start-page: 1500
  year: 2020
  ident: ref_39
  article-title: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: The CORONADO study
  publication-title: Diabetologia
  doi: 10.1007/s00125-020-05180-x
– volume: 129
  start-page: 636.e1
  year: 2016
  ident: ref_6
  article-title: Uptake of Influenza Vaccination and Missed Opportunities Among Adults with High-Risk Conditions, United States, 2013
  publication-title: Am. J. Med.
  doi: 10.1016/j.amjmed.2015.10.031
SSID ssj0032572
Score 2.2427354
Snippet Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of...
: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on...
SourceID doaj
pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 219
SubjectTerms Adult
clinical pharmacist
Coronaviruses
COVID-19 vaccines
Diabetes
Diabetes Mellitus, Type 2
Drug stores
Endocrinology
Expected values
Female
Hepatitis
Hospitalization
Hospitals
Humans
Immunization
Infections
Influenza
Influenza Vaccines
Life Sciences
Medical records
Middle Aged
Patients
people living with diabetes
Pharmaceuticals
Pharmacists
Population
Questionnaires
Tetanus
Vaccination
Vaccination Coverage
Whooping cough
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSFd2mgIIO4cIh2Ezu2wwUtpVWRlqpCgPYW-UkjoaTd3Vbiyi9nxvEu3SL1wjUeJ7E8nvnm4RlC3lgxlg4sq9yBrMt5FWyuhRG5ZM4Y57Emm4vNJuTRkZrN6uPkcFuktMqVTIyC2vUWfeQjrCuOjWJE-f70LMeuURhdTS00bpJb2DYb-VzO1gYXA3Ycop0ga4QYz4YwJQMzf5Qi17pSgJdKrLNzSS3F6v2gbE4wN_Jf4Hk1f_KSQjq4_79LeUDuJShKJwPvPCQ3fPeI3Pmcgu2Pye9P8QYl7QNddRdJlzZp21Hd0f0OvjVvB888_QiKbR5z1ilQfNcWFx6p9zBNFOQWTjuOGet02qIjg6IXmKaknMU7OqFfALfm0zZ4igmOv56Qbwf7X_cO89SyIbdVyZe5VrwOhVYi6MA9V7YuytJLD1aNNtwxgG82cMG8sEoaP2aSmbrUTgdd-AKg1DbZ6vrO7xCKDXRcAICBRqiVooYJlQd4qJSvrCsyMlrtWGNTPXNsq_GzAbsG97i5uscZebuecTrU8riG9gMywZoOq3DHB_38R5MOdcN94NxLI6y3vHC1VoaBzHSuNEYEozPyGlho4x2Hk2mDz8YMC7OJ6gLWsbvikibJj0Xzl0Uy8mo9DCcfwzm68_15pGGqkqxSGXk6MOT6UwCrAUtznhG5waob_7I50rUnsbo4aJ26LuWz63_rOblb4kWQmL--S7aW83P_gty2F8t2MX8Zj-Ef5Ec9eQ
  priority: 102
  providerName: ProQuest
Title Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study
URI https://www.ncbi.nlm.nih.gov/pubmed/35208544
https://www.proquest.com/docview/2632962762
https://www.proquest.com/docview/2633857358
https://hal.science/hal-03563065
https://pubmed.ncbi.nlm.nih.gov/PMC8879927
https://doaj.org/article/4ef44e7b6cec41d9a8b3307dd2bb6fba
Volume 58
WOSCitedRecordID wos000767996200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: 7X7
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: BENPR
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: PIMPY
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgIMQL4nMERmUQLzxEbWLHdnjrRqdN6qpoAlSeIn9qkVCK2m4Sr_zl3Dlp1Q4JXniJlOScuvb57ne-8x0h760YSQeWVepA1qW8CDbVwohUMmeM85iTzcViE3I2U_N5We2U-sKYsC49cDdwQ-4D514aYb3lmSu1MmCCS-dyY0QwERrBBzfGVCeDGTBi5-cEKSPEaN45KBkY-MPeZ60LBUgpxww7Owop5u0HNXOFUZF_Qs7bkZM7quj0MXnUY0g67vr-hNzx7VPy4KL3kj8jv87j0Ue6CHRTFqQ_bUmbluqWTlq3AGnRbanTT6CRljHYnALFV22x35H6BOM7QeBgsyqGmtNpgzsQFLdvaR9Ns_pIx_QSAGc6bYKnGJn48zn5cjr5fHKW9rUWUlvkfJ1qxcuQaSWCDtxzZcssz730YI5owx0D3GUDF8wLq6TxIyaZKXPtdNCZzwADvSAH7aL1LwnFyjcuADJA69FKUUKDwgOuU8oX1mUJGW4GvLZ9InKsh_G9BoMEp6i-PUUJ-bBt8aNLwvEX2mOcwy0dps-OD4Cp6p6p6n8xVULeAQfsfeNsPK3x2YhhRjVR3MD_ONowSN0v_FWN6e-xnpHIE_J2-xqWLPphdOsX15GGqUKyQiXksOOn7U8BHgYQzHlC5B6n7fVl_03bXMW04KAuyjKXr_7HALwmD3M85xHD04_IwXp57d-Q-_Zm3ayWA3JXzmW8qgG5dzyZVZeDuP7grjq_qL79BkEVNnw
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQwCA4cIg2iR3bQUJo6UO76nZVoYL2FhzboZFQtuxui3rlB_EbmXGSpVuk3nrgmoyziXf8zYzn8wwhr42IpIXIKrSAdSFPSxNqUYhQMlsU1mFNNuubTcjxWE0m2f4a-d2dhUFaZYeJHqjt1OAeeQ_rimOjGJF8OPoRYtcozK52LTQatdh1pz8hZJu_H27B__smSXa2DzYHYdtVIDRpwhehVjwrY61EqUvuuDJZnCROOnC8dcEtAw_DlFwwJ4yShYuYZEWWaKtLHbsYrD089wq5CjguMdiTk2WAx0D9m-wqYJsQ0aRJizKWRb02U65TBf5ZgnV9zphB3y0AjNshcjH_dXTP8zXPGMCd2__b1N0ht1pXm_abtXGXrLn6Hrm-15IJ7pNfQ39ClE5L2nVPaQ-l0qqmuqbbNXzbrGoyD3QLDPfMc_IpSHzRBifaS28iDRZwGYfte0Y-HVW4UUNxl5u2pKP5O9qnn8AvD0dV6SgSOE8fkM-XMgMPyXo9rd1jQrFBkC3BgcIg20iRwYDUgfurlEuNjQPS6zQkN229dmwb8j2HuA11Kj-vUwF5uxxx1NQquUD2IyrdUg6rjPsL09m3vAWtnLuScycLYZzhsc20KhjYBGuTohBloQPyClR25RmD_ijHaxHDwnMiPYHv2Oi0Mm_xcZ7_VcmAvFzeBmTDdJWu3fTYyzCVSpaqgDxqFsDypyBsgFiB84DIlaWx8i6rd-rq0FdPB6uaZYl8cvFrvSA3Bgd7o3w0HO8-JTcTPPTiufobZH0xO3bPyDVzsqjms-ceAij5etkL5w8pu5tH
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VFFVceD8MBRYEBw5W7N312kZCKDSNGjWNIgQoPZn1Pqgl5JQkLeqVn8WvY8aP0BSptx642rO2dz3PnW9nCHmlZRAbiKx8A7rOF5HTvpK59GNu8txYrMlmqmYT8XicTKfpZIP8bs_CIKyy1YmVojYzjXvkXawrjo1iJOu6BhYx6Q_eH__wsYMUZlrbdho1i-zbs58Qvi3eDfvwr18zNtj9tLPnNx0GfB0xsfRVIlIXqkQ65YQViU5DxmxswQlXuTAcvA3thORW6iTObcBjnqdMGeVUaEOw_PDca2QTXHLBOmRzMjyYHLZ2gIMw1LlW0HRSBtM6Scp5GnSbvLmKEvDWGFb5OWcUq94BYOqOEJn5r9t7Eb15zhwObv3PC3mb3GyccNqrpeYO2bDlXbJ10MAM7pFfw-rsKJ052vZVaY6r0qKkqqS7JcxzXtQ5CdoHkz6v0PoUKL4ojYteUe8gQBY0Ng6bVFh9OipwC4fi_jdt4EiLt7RHP4LH7o8KZylCO8_uk89XsgIPSKeclfYRodg6yDhwrTD81rFMYUBkwTFOEhtpE3qk23JLpptK7thQ5HsGER3yV3aRvzzyZjXiuK5icgntB2TAFR3WH68uzObfskadZcI6IWycS221CE2qkpyDtTCG5bl0ufLIS2DftWfs9UYZXgs4lqST0SnMY7vl0KzRnIvsL3t65MXqNug8TGSp0s5OKhqeRDGPEo88rIVh9SoIKCCKEMIj8ZqYrH3L-p2yOKrqqoO9TVMWP778s56TLZCXbDQc7z8hNxiehqlA_Nuks5yf2Kfkuj5dFov5s0YfUPL1qiXnD6f_pZY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Hospitalization+in+an+Endocrinology+Department+on+Vaccination+Coverage+in+People+Living+with+Diabetes%3A+A+Real-Life+Study&rft.jtitle=Medicina+%28Kaunas%2C+Lithuania%29&rft.au=Lohan%2C+Laura&rft.au=Cool%2C+Charl%C3%A8ne&rft.au=Viault%2C+Loriane&rft.au=Cestac%2C+Philippe&rft.date=2022-02-01&rft.issn=1648-9144&rft.eissn=1648-9144&rft.volume=58&rft.issue=2&rft.spage=219&rft_id=info:doi/10.3390%2Fmedicina58020219&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_medicina58020219
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1648-9144&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1648-9144&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1648-9144&client=summon